3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Small Cell Lung Carcinoma
1
Sleep Wake Disorders
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Malignant Primary Pelvic Neoplasm
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Inflammatory Breast Neoplasms
1
Hodgkin Disease
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
Heart Defects, Congenital
1
Fatigue
1
Depression
1
Colonic Neoplasms
1
Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8
1
Carcinoma, Merkel Cell
1
Anxiety Disorders
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Therapeutics
2
Exercise
2
enzalutamide
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
darolutamide
1
auricularum
1
apalutamide
1
Therapeutic Touch
1
Testosterone
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Sildenafil Citrate
1
Relaxation Therapy
1
Radiotherapy
1
Quality of Life
1
Methods
1
Gels
1
Exercise Test
1
Electroacupuncture
1
Educational Status
1
Early Intervention, Educational
1
Dexamethasone
1
Counseling
1
Consolidation Chemotherapy
1
Chemoradiotherapy
1
Calcium Dobesilate
1
Autogenic Training
1
Acupressure
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fatigue
×
Exercise Test
×
90 days
×
Clear all
NCT00819208
2026-04-24
CHALLENGE
Canadian Cancer Trials Group
Phase NA
Completed
889 enrolled
9 charts